Vanderbilt Eye Institute, Vanderbilt University Medical Center, Nashville, Tennessee, 37203, USA.
Br J Ophthalmol. 2012 Mar;96(3):318-22. doi: 10.1136/bjophthalmol-2011-300801. Epub 2011 Dec 23.
Axenfeld-Rieger syndrome is a genetic disease affecting multiple organ systems. In the eye, this condition manifests with varying degrees of anterior segment dysgenesis and carries a high risk of glaucoma. Other associated systemic issues include cardiovascular outflow tract malformations, craniofacial abnormalities and pituitary abnormalities, which can result in severe endocrinological sequelae. Recent advances in molecular genetics have identified two major genes, PITX2 and FOXC1, demonstrating a wide spectrum of mutations, which aids in the molecular diagnosis of the disease, although evidence exists to implicate other loci in this condition. The management of individuals affected by Axenfeld-Rieger syndrome requires a multidisciplinary approach and would include dedicated surveillance and management of glaucoma, sensorineural hearing loss, and cardiac, endocrinological, craniofacial and orthopaedic abnormalities.
Axenfeld-Rieger 综合征是一种影响多个器官系统的遗传疾病。在眼部,这种疾病表现为不同程度的眼前段发育不良,并伴有很高的青光眼风险。其他相关的全身问题包括心血管流出道畸形、颅面异常和垂体异常,这可能导致严重的内分泌后遗症。分子遗传学的最新进展已经确定了两个主要基因,即 PITX2 和 FOXC1,显示出广泛的突变,这有助于疾病的分子诊断,尽管有证据表明其他基因座也与这种情况有关。Axenfeld-Rieger 综合征患者的管理需要多学科方法,包括专门的青光眼、感觉神经性听力损失以及心脏、内分泌、颅面和骨科异常的监测和管理。